Peritoneal cytology: endometrium case
A case series of peritoneal cytology from an elderly woman with an endometrial mass was shared with four diagnostic photos, illustrating how effusion sampling can capture cells shed from an intra‑abdominal malignancy (x.com). The post circulated widely in pathology circles as a teaching example of correlating clinical mass location with peritoneal cytology appearances (x.com).
Peritoneal cytology is the microscope exam of fluid from the abdominal cavity, looking for cells that have floated off a tumor the way leaves drift into a pond. In gynecologic cancers, that fluid can sometimes show malignancy even before a larger tissue sample is reviewed. (cytojournal.com) The case circulating in pathology circles used peritoneal fluid from an older woman with an endometrial mass to show that an intra-abdominal cancer can shed recognizable cells into an effusion sample. The teaching point was clinicopathologic correlation: matching what clinicians know about the mass in the uterus with what cytologists see on the slide. (x.com) Endometrial cancer starts in the endometrium, the inner lining of the uterus, and it is the most common gynecologic malignancy in the United States. The National Cancer Institute estimated 69,120 new uterine corpus cancers and 13,860 deaths in 2025, and most cases are found early because abnormal bleeding often appears early. (cancer.gov) Serous fluid cytology now uses a standardized reporting system with five categories: nondiagnostic, negative for malignancy, atypia of undetermined significance, suspicious for malignancy, and malignant. That framework was published to make body-fluid diagnoses more consistent across laboratories and to tie slide findings to imaging and clinical history. (pathologyoutlines.com) In practice, these samples come in two main forms. Ascitic fluid is fluid that has built up in the abdomen on its own, while peritoneal washings are saline collected at the start of surgery to sample the cavity for stray tumor cells. (karger.com) That distinction matters because washings can contain benign look-alikes. Reactive mesothelial cells, endosalpingiosis, endometriosis, and tumor rupture can all mimic cancer cells, which is why cytology is read alongside the patient’s imaging, operation notes, and tumor type. (cytojournal.com) In endometrial cancer, positive peritoneal cytology has been debated for years. The International Federation of Gynecology and Obstetrics removed cytology from endometrial cancer staging in 2009, but newer studies continue to report links between malignant washings and worse outcomes in some groups. (gynecologiconcology-online.net) A 2025 International Journal of Gynecological Cancer study said positive peritoneal cytology is a known risk factor for worse oncologic outcomes, but it is not used for staging or to guide adjuvant treatment. A 2024 systematic review likewise found it appeared to be a negative prognostic indicator, while calling for more data that include molecular tumor profiles. (international-journal-of-gynecological-cancer.com) (pmc.ncbi.nlm.nih.gov) That is why a four-image teaching case can travel so far in pathology. It compresses a larger lesson into one slide set: fluid cytology can be the first clue, but the final call depends on where the mass is, what tumor is suspected, and whether the cells fit that clinical picture. (x.com)
